Yacouba Toloba
Research Subjects
Research Interests
Yacouba Toloba has a total of 163 co-authors. Here are the top co-authors by number of shared publications:
S. Diallo
Service de pneumologie, CHU du Point-G, E1631 Bamako, Mali; Centre de formation et de recherche (SEREFO), Mali
24 shared publicationsK. Ouattara
Service de pneumologie, CHU du Point-G, E1631 Bamako, Mali
18 shared publicationsB.F. Sissoko
15 shared publicationsD. Soumaré
Service de pneumologie, CHU du Point-G, E1631 Bamako, Mali
15 shared publicationsB. Baya
Service de pneumologie, CHU du Point-G, E1631 Bamako, Mali
10 shared publicationsG. Berthé
Service de pneumologie, CHU du Point-G, E1631 Bamako, Mali
10 shared publications
Latest Publications
- 17 August 2022
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 107 (2) , 433-440
Sex Differences in Active Pulmonary Tuberculosis Outcomes in Mali, West Africa
: Men and women often respond differently to infectious diseases and their treatments. Tuberculosis (TB) is a life-threatening communicable disease that affects more men than women globally. Whether male sex is an independent risk factor for unfavorable TB outcomes, however, has not been rigorously investigated in an African context, where individuals are likely exposed to different microbial and environmental factors. We analyzed data collected from a cohort study in Mali by focusing on newly diagnosed active pulmonary TB individuals who were treatment naive. We gathered baseline demographic, clinical, and microbiologic characteristics before treatment initiation and also at three time points during treatment. More males than females were affected with TB, as evidenced by a male-to-female ratio of 2.4:1. In addition, at baseline, males had a significantly higher bacterial count and shorter time to culture positivity as compared with females. Male sex was associated with lower smear negativity rate after 2 months of treatment also known as the intensive phase of treatment, but not at later time points. There was no relationship between patients’ sex and mortality from any cause during treatment. This study suggests that sex-based differences in TB outcomes exist, with sex-specific effects on disease outcomes being more pronounced before treatment initiation and during the intensive phase of treatment rather than at later phases of treatment.
- 17 August 2022
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 107 (2) , 433-440
Sex Differences in Active Pulmonary Tuberculosis Outcomes in Mali, West Africa
: Men and women often respond differently to infectious diseases and their treatments. Tuberculosis (TB) is a life-threatening communicable disease that affects more men than women globally. Whether male sex is an independent risk factor for unfavorable TB outcomes, however, has not been rigorously investigated in an African context, where individuals are likely exposed to different microbial and environmental factors. We analyzed data collected from a cohort study in Mali by focusing on newly diagnosed active pulmonary TB individuals who were treatment naive. We gathered baseline demographic, clinical, and microbiologic characteristics before treatment initiation and also at three time points during treatment. More males than females were affected with TB, as evidenced by a male-to-female ratio of 2.4:1. In addition, at baseline, males had a significantly higher bacterial count and shorter time to culture positivity as compared with females. Male sex was associated with lower smear negativity rate after 2 months of treatment also known as the intensive phase of treatment, but not at later time points. There was no relationship between patients’ sex and mortality from any cause during treatment. This study suggests that sex-based differences in TB outcomes exist, with sex-specific effects on disease outcomes being more pronounced before treatment initiation and during the intensive phase of treatment rather than at later phases of treatment.
- Open Access
- 1 April 2019
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 81, 149-155
Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali
- 1 April 2019
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 81, 149-155
Open AccessClinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali
- 1 February 2018
- Published by Elsevier in Revue de Pneumologie Clinique
- Vol. 74 (1) , 22-27
Tuberculose multi-résistante (TB-MR) en milieu carcéral noir africain : expérience du Mali
- 1 February 2018
- Published by Elsevier in Revue de Pneumologie Clinique
- Vol. 74 (1) , 22-27
Tuberculose multi-résistante (TB-MR) en milieu carcéral noir africain : expérience du Mali
- 1 January 2018
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 35, A265-A266
Miliaire tuberculeuse : profil épidémioclinique et évolution
- 1 January 2018
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 35, A265-A266
Miliaire tuberculeuse : profil épidémioclinique et évolution
- Open Access
- 6 November 2017
- Published by Springer Nature in BMC Research Notes
- Vol. 10 (1) , 561
Extensively drug resistant tuberculosis in Mali: a case report
Drug resistant tuberculosis presents a major public health challenge. We present here the first two patients diagnosed with extensively drug resistant tuberculosis in Bamako, Mali. Genotypic findings suggest possible nosocomial transmission from the first patient to the second one, resulting in superinfection of the second patient. After being diagnosed with extensively drug resistant tuberculosis in August 2016, the patients only started receiving appropriate treatment 10 months later. The identification of these patients highlights the need for improved diagnostic and treatment algorithms for better surveillance and management of drug resistance in Mali. In the interest of these as well as future patients suffering from resistant tuberculosis, all steps recommended for programmatic management of drug resistant tuberculosis must be urgently prioritized in order to strengthen the multidrug resistant tuberculosis program.
- 6 November 2017
- Published by Springer Nature in BMC Research Notes
- Vol. 10 (1) , 561
Open AccessExtensively drug resistant tuberculosis in Mali: a case report
Drug resistant tuberculosis presents a major public health challenge. We present here the first two patients diagnosed with extensively drug resistant tuberculosis in Bamako, Mali. Genotypic findings suggest possible nosocomial transmission from the first patient to the second one, resulting in superinfection of the second patient. After being diagnosed with extensively drug resistant tuberculosis in August 2016, the patients only started receiving appropriate treatment 10 months later. The identification of these patients highlights the need for improved diagnostic and treatment algorithms for better surveillance and management of drug resistance in Mali. In the interest of these as well as future patients suffering from resistant tuberculosis, all steps recommended for programmatic management of drug resistant tuberculosis must be urgently prioritized in order to strengthen the multidrug resistant tuberculosis program.
- 1 September 2017
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 34 (7) , 729-733
Pathologies respiratoires en milieu carcéral noir africain
- 1 September 2017
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 34 (7) , 729-733
Pathologies respiratoires en milieu carcéral noir africain
- 1 January 2017
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 34, A261
Profils de sensibilisation cutanée aux pneumallergènes des patients consultant pour allergie respiratoire à Bamako
- 1 January 2017
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 34, A261
Profils de sensibilisation cutanée aux pneumallergènes des patients consultant pour allergie respiratoire à Bamako
- 1 January 2017
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 34, A233
Modification du profil épidémiologique de la tuberculose
- 1 January 2017
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 34, A233
Modification du profil épidémiologique de la tuberculose
- 1 January 2017
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 34, A228
Motif d’hospitalisation des cas de TPM+ en milieu hospitalier phtisiologique
- 1 January 2017
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 34, A228
Motif d’hospitalisation des cas de TPM+ en milieu hospitalier phtisiologique
- 1 January 2017
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 34, A216-A217
Apport du GeneXpert dans le diagnostic de la tuberculose et de la résistance à la rifampicine au Mali après 22 mois d’acquisition
- 1 January 2017
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 34, A216-A217
Apport du GeneXpert dans le diagnostic de la tuberculose et de la résistance à la rifampicine au Mali après 22 mois d’acquisition